These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25520592)

  • 1. Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations.
    Ye M; Tang L; Luo M; Zhou J; Guo B; Liu Y; Chen B
    Nanoscale Res Lett; 2014; 9(1):642. PubMed ID: 25520592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLM chip - A microfluidic approach to study the mechanistic basis of cytochrome P450 inhibition using immobilized human liver microsomes.
    Pihlaja T; Kiiski I; Sikanen T
    Eur J Pharm Sci; 2024 Jun; 197():106773. PubMed ID: 38641124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Varghese A; Savai J; Pandita N; Gaud R
    Toxicol Rep; 2015; 2():806-816. PubMed ID: 28962416
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
    Olesen OV; Linnet K
    Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes].
    Li AF; Shen GL; Jiao SY; Li H; Wang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):431-6. PubMed ID: 22692316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.
    Rochat B; Amey M; Gillet M; Meyer UA; Baumann P
    Pharmacogenetics; 1997 Feb; 7(1):1-10. PubMed ID: 9110356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
    Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
    Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
    Tang L; Ye L; Lv C; Zheng Z; Gong Y; Liu Z
    Toxicol Lett; 2011 Apr; 202(1):47-54. PubMed ID: 21277363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol.
    Cho PJ; Paudel S; Lee D; Jin YJ; Jo G; Jeong TC; Lee S; Lee T
    Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30200214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
    Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
    Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis.
    Chen J; Farrell GC
    J Gastroenterol Hepatol; 1996 Sep; 11(9):870-7. PubMed ID: 8889968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Phase I and Phase II Hepatic Metabolism and Reactive Intermediates of Larrea nitida Cav. and Its Lignan Compounds.
    Jeong H; Kim S; Lee J; Park JY; Zhou W; Liu X; Kim SD; Song YS; Jang CY; Oh SR; Choi S; Chang M
    Phytother Res; 2017 Jan; 31(1):140-151. PubMed ID: 28058783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
    Han SY; Zhao HY; Zhou N; Zhou F; Li PP
    J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of biomolecule function by nanoparticles: how do gold nanoparticles affect Phase I biotransformation of persistent organic pollutants?
    Lu Z; Ma G; Veinot JG; Wong CS
    Chemosphere; 2013 Sep; 93(1):123-32. PubMed ID: 23763865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.